Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alcoholism
Research by M.H. Jarrar and colleagues in alcoholism provides new insights
April 20th, 2008
" Several adipocytokines have been implicated in the pathogenesis nonalcoholic fatty liver disease (NAFLD). To assess adipocytokines in NAFLD patients and controls," scientists writing in the journal Alimentary Pharmacology & Therapeutics report. " A total of 95 patients (26 non-alcoholic steatohepatitis (NASH), 19 simple steatosis (SS), 38 obese controls and 12 non-obese controls) were included. Fasting serum insulin, glucose, visfatin, resistin, adiponectin, tumour necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8) and IL-6 were determined. Univariate and multivariate analyses were used to compare groups and determine associations. Serum TNF-a and IL-8...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-20)
|
